Slc15a4, a Gene Required for pDC Sensing of TLR Ligands, Is Required to Control Persistent Viral Infection

PLoS Pathogens

Volumn 8, Issue 9, 2012, Pages

  Blasius, Amanda L ^a   Krebs, Philippe ^a,b   Sullivan, Brian M ^a   Oldstone, Michael B ^a   Popkin, Daniel L ^a,c  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; OVALBUMIN; SOLUTE CARRIER FAMILY 15 MEMBER 4 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARENAVIRUS INFECTION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; DISEASE COURSE; GENE FUNCTION; IMMUNOSTIMULATION; IN VIVO STUDY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS INFECTION; LYMPHOCYTOTOXICITY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PROTEIN FUNCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRAL CLEARANCE; VIREMIA; VIRUS IMMUNITY; VIRUS INHIBITION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINES; CYTOKINES; DENDRITIC CELLS; IMMUNITY, INNATE; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED C57BL; TOLL-LIKE RECEPTORS; VIREMIA;

MUS;

EID: 84866928409     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002915     Document Type: Article

References (35)

1. Colonna M, Krug A, Cella M, (2002) Interferon-producing cells: on the front line in immune responses against pathogens. Curr Opin Immunol 14: 373-379.
2. Asselin-Paturel C, Boonstra A, Dalod M, Durand I, Yessaad N, et al. (2001) Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat Immunol 2: 1144-1150.
3. Bjorck P, (2001) Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor-treated mice. Blood 98: 3520-3526.
4. Nakano H, Yanagita M, Gunn MD, (2001) CD11c(+)B220(+)Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J Exp Med 194: 1171-1178.
5. Swiecki M, Colonna M, (2010) Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance Immunol Rev 234: 142-162.
6. Cisse B, Caton ML, Lehner M, Maeda T, Scheu S, et al. (2008) Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell 135: 37-48.
7. Swiecki M, Gilfillan S, Vermi W, Wang Y, Colonna M, (2010) Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual. Immunity 33: 955-966.
8. Takagi H, Fukaya T, Eizumi K, Sato Y, Sato K, et al. (2011) Plasmacytoid dendritic cells are crucial for the initiation of inflammation and T cell immunity invivo. Immunity 35: 958-971.
9. Blasius AL, Arnold CN, Georgel P, Rutschmann S, Xia Y, et al. (2010) Slc15a4, AP-3, and Hermansky-Pudlak syndrome proteins are required for Toll-like receptor signaling in plasmacytoid dendritic cells. Proc Natl Acad Sci U S A 107: 19973-19978.
10. Sasawatari S, Okamura T, Kasumi E, Tanaka-Furuyama K, Yanobu-Takanashi R, et al. (2011) The solute carrier family 15A4 regulates TLR9 and NOD1 functions in the innate immune system and promotes colitis in mice. Gastroenterology 140: 1513-1525.
11. Khanolkar A, Fuller MJ, Zajac AJ, (2002) T cell responses to viral infections: lessons from lymphocytic choriomeningitis virus. Immunol Res 26: 309-321.
12. Kim PS, Ahmed R, (2010) Features of responding T cells in cancer and chronic infection. Curr Opin Immunol 22: 223-230.
13. Zuniga EI, McGavern DB, Pruneda-Paz JL, Teng C, Oldstone MB, (2004) Bone marrow plasmacytoid dendritic cells can differentiate into myeloid dendritic cells upon virus infection. Nat Immunol 5: 1227-1234.
14. Torti N, Walton SM, Murphy KM, Oxenius A, (2011) Batf3 transcription factor-dependent DC subsets in murine CMV infection: differential impact on T-cell priming and memory inflation. Eur J Immunol 41: 2612-2618.
15. Schoenberger SP, van der Voort EI, Krietemeijer GM, Offringa R, Melief CJ, et al. (1998) Cross-priming of CTL responses in vivo does not require antigenic peptides in the endoplasmic reticulum of immunizing cells. J Immunol 161: 3808-3812.
16. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, et al. (1994) T cell receptor antagonist peptides induce positive selection. Cell 76: 17-27.
17. Cerny A, Huegin AW, Sutter S, Bazin H, Hengartner HH, et al. (1986) Immunity to lymphocytic choriomeningitis virus in B cell-depleted mice: evidence for B cell and antibody-independent protection by memory T cells. Eur J Immunol 16: 913-917.
18. Welsh RM, Dundon PL, Eynon EE, Brubaker JO, Koo GC, et al. (1990) Demonstration of the antiviral role of natural killer cells in vivo with a natural killer cell-specific monoclonal antibody (NK 1.1). Nat Immun Cell Growth Regul 9: 112-120.
19. Aichele P, Unsoeld H, Koschella M, Schweier O, Kalinke U, et al. (2006) CD8 T cells specific for lymphocytic choriomeningitis virus require type I IFN receptor for clonal expansion. J Immunol (Baltimore, Md: 1950) 176: 4525-4529.
20. Havenar-Daughton C, Kolumam GA, Murali-Krishna K, (2006) Cutting Edge: The direct action of type I IFN on CD4 T cells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection. J Immunol (Baltimore, Md: 1950) 176: 3315-3319.
21. Kolumam GA, Thomas S, Thompson LJ, Sprent J, Murali-Krishna K, (2005) Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med 202: 637-650.
22. Thompson LJ, Kolumam GA, Thomas S, Murali-Krishna K, (2006) Innate inflammatory signals induced by various pathogens differentially dictate the IFN-I dependence of CD8 T cells for clonal expansion and memory formation. J Immunol (Baltimore, Md: 1950) 177: 1746-1754.
23. Wiesel M, Kratky W, Oxenius A, (2011) Type I IFN substitutes for T cell help during viral infections. J Immunol (Baltimore, Md: 1950) 186: 754-763.
24. Conry SJ, Milkovich KA, Yonkers NL, Rodriguez B, Bernstein HB, et al. (2009) Impaired plasmacytoid dendritic cell (PDC)-NK cell activity in viremic human immunodeficiency virus infection attributable to impairments in both PDC and NK cell function. J Virol 83: 11175-11187.
25. Drobits B, Holcmann M, Amberg N, Swiecki M, Grundtner R, et al. (2012) Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells. J Clin Invest 122: 575-585.
26. Cervantes-Barragan L, Lewis KL, Firner S, Thiel V, Hugues S, et al. (2012) Plasmacytoid dendritic cells control T-cell response to chronic viral infection. Proc Natl Acad Sci U S A 109: 3012-3017.
27. Bocharov G, Ludewig B, Bertoletti A, Klenerman P, Junt T, et al. (2004) Underwhelming the immune response: effect of slow virus growth on CD8+-T-lymphocyte responses. J Virol 78: 2247-2254.
28. Wang Y, Swiecki M, Cella M, Alber G, Schreiber RD, et al. (2012) Timing and Magnitude of Type I Interferon Responses by Distinct Sensors Impact CD8 T Cell Exhaustion and Chronic Viral Infection. Cell Host Microbe 11: 631-642.
29. Ou R, Zhou S, Huang L, Moskophidis D, (2001) Critical role for alpha/beta and gamma interferons in persistence of lymphocytic choriomeningitis virus by clonal exhaustion of cytotoxic T cells. J Virol 75: 8407-8423.
30. Matloubian M, Concepcion RJ, Ahmed R, (1994) CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J Virol 68: 8056-8063.
31. Oldstone MB, Blount P, Southern PJ, Lampert PW, (1986) Cytoimmunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system. Nature 321: 239-243.
32. Rietdijk ST, Burwell T, Bertin J, Coyle AJ, (2008) Sensing intracellular pathogens-NOD-like receptors. Curr Opin Pharmacol 8: 261-266.
33. Woltman AM, Op den Brouw ML, Biesta PJ, Shi CC, Janssen HL, (2011) Hepatitis B virus lacks immune activating capacity, but actively inhibits plasmacytoid dendritic cell function. PLoS One 6: e15324.
34. Liang H, Russell RS, Yonkers NL, McDonald D, Rodriguez B, et al. (2009) Differential effects of hepatitis C virus JFH1 on human myeloid and plasmacytoid dendritic cells. J Virol 83: 5693-5707.
35. Popkin DL, Teijaro JR, Sullivan BM, Urata S, Rutschmann S, et al. (2011) Hypomorphic mutation in the site-1 protease Mbtps1 endows resistance to persistent viral infection in a cell-specific manner. Cell Host Microbe 9: 212-222.